A blood-based biomarker assay for multiple sclerosis (MS) disease activity provides actionable insights that supplement standard MS evaluations, especially for treatment initiation and de-escalation ...

Though relapsing-remitting multiple sclerosis, or RRMS, can be managed with many of the approved treatments for MS symptoms, there is still no scientifically proven, FDA-cleared way to predict when or ...

MS research suggests the disease may be divided into two biological subtypes that differ in how early and aggressively nerve ...

Researchers have created a blood test to detect multiple sclerosis (MS) patients' immunological responses, which may help us understand and treat the disease. Around 2.8 million individuals worldwide ...

Artificial intelligence (AI), using a simple blood test combined with standard brain images has, for the first time, been ...

A test that measures kappa immunoglobulin free light chains in cerebrospinal fluid (KCSF) is a valid option for diagnosing multiple sclerosis (MS), new research suggests. Results showed that compared ...

The U.S. FDA granted Roche Holding AG breakthrough device designation for its Elecsys Neurofilament Light Chain test for multiple sclerosis. The Elecsys NfL test can aid in the detection of disease ...

There may be two distinct subtypes of multiple sclerosis, according to a new study led by scientists at University College ...

An estimated 2.8 million people worldwide have multiple sclerosis (MS). This autoimmune condition is the result of the immune system damaging parts of the nerves in the brain and spinal cord, which ...

Researchers have validated a new antibody test to diagnose multiple sclerosis (MS), a potentially disabling disease of the brain and spinal cord. Mayo Clinic researchers have validated a new antibody ...

A research team at the Medical University of Vienna has developed a blood test that allows the identification of individuals at risk for developing multiple sclerosis (MS) with a high degree of ...

A previously "hidden" subtype of Multiple Sclerosis (MS)—a condition that affects the brain and spinal cord—has been uncovered. The distinct subtype exhibits "significant cognitive deficits with ...